Efficacy of topically administered fluralaner or imidacloprid/moxidectin on dogs with generalised demodicosis

被引：0

作者：

Josephus J. Fourie

Leon Meyer

Emmanuel Thomas

机构：

[1] Clinvet International (Pty) Ltd,

[2] Clinvet Morocco,undefined

[3] Douar Dbabej,undefined

[4] MSD Animal Health Innovation GmbH,undefined

来源：

Parasites & Vectors | / 12卷

关键词：

Bravecto; Spot-on Solution; Fluralaner; Advocate®; Spot-on; Imidacloprid; Moxidectin; Efficacy; Dogs; Generalised demodicosis; Mange;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 29 条

[1]

Fourie JJ(2015)Efficacy of orally administered fluralaner (Bravecto™) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs Parasit Vectors. 8 187-e107

[2]

Liebenberg JE(2016)Efficacy of fluralaner administered either orally or topically for the treatment of naturally acquired Parasit Vectors. 9 392-undefined

[3]

Horak IG(2017) var. Parasit Vectors. 10 30-undefined

[4]

Taenzler J(2014) infestation in dogs Parasit Vectors. 7 85-undefined

[5]

Heckeroth AR(2016)Efficacy of fluralaner against Parasit Vectors. 9 296-undefined

[6]

Frénais R(2017) infestations in dogs and cats Vet Dermatol. 5 468-undefined

[7]

Taenzler J(undefined)Pharmacokinetics of fluralaner in dogs following a single oral or intravenous administration undefined undefined undefined-undefined

[8]

Liebenberg J(undefined)Comparative pharmacokinetics of fluralaner in dogs and cats following single topical or intravenous administration undefined undefined undefined-undefined

[9]

Roepke RK(undefined)Afoxolaner and fluralaner treatment do not impact on cutaneous undefined undefined undefined-undefined

[10]

Frénais R(undefined) populations of healthy dogs undefined undefined undefined-undefined

← 1 2 3 →